Evestra Snags DoD Grant For Experimental Breast Cancer Drug Research

By David Holley, Xconomy San Antonio—A small Texas biotech that develops women’s health ...

Promising Treatment for Ebola Virus to be Tested at Texas Biomed

Ricardo Carrion, Jr., Ph.D. During the West African Ebola outbreak that began in 2013, an experimental ...

Methodist Healthcare has received national recognition for innovative cancer program
October 18, 2013

Methodist Healthcare has been recognized nationally for quality cancer care (Photo courtesy of Methodist)

By W. Scott Bailey, San Antonio Business Journal

Methodist Healthcare System's Methodist Cancer Center has earned national accolades for its work in the fight against cancer.

The Association of Community Cancer Centers (ACCC) has recognized Methodist for developing a process for rapid assessment and management of cancer patients with low white blood cell counts, giving its 2013 Innovator Award to the San Antonio institution.

That process, named the Very Immunocompromised Patient, or VIP, Program was developed by a multidisciplinary team at Methodist Cancer Center. As part of the program, oncology patients are quickly evaluated and treated in Methodist's emergency department. Patients are given VIP kits that educate them on when to report to the emergency department. One of the by-products of the program is an improved coordination of care with community-based physicians.

ACCC's Innovator Awards recognize exceptional cancer programs that exhibit forward-thinking, strategic planning, and which have developed pioneering, replicable programs for cancer-care delivery.

Other Texas institutions receiving the ACCC Innovator Award include Texas Health Harris Methodist Hospital's Klabzuba Cancer Center in Fort Worth, and the University of Texas Southwestern Medical Center's Harold C. Simmons Comprehensive Cancer Center in Dallas.

W. Scott Bailey covers health care, tourism, sports business, economic development; he also plans and edits some special reports.


Stay informed. Subscribe to BioMed SA news alerts.